Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Tetrahydrofuran Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111303083A reveals a green hydroaminocarbonylation route for 3-aminomethyl tetrahydrofuran. Achieve cost reduction in agrochemical intermediate manufacturing with scalable, high-purity production.
Patent CN107935970A enables high-purity low-water 3-methylamine tetrahydrofuran production. Significant cost reduction and supply chain reliability for dinotefuran manufacturing intermediates.
Novel Rh-catalyzed one-pot route for spiro-oxindoles. High yield, mild conditions. Reliable pharmaceutical intermediate supplier for oncology drug development.
Novel gamma-butyrolactone route for 3-hydroxymethyl tetrahydrofuran. High yield, low cost agrochemical intermediate manufacturing process suitable for industrial scale-up.
Patent CN110669027B discloses efficient synthesis of tetrahydrofuran carboxylic acid intermediates for prostate cancer drugs, offering scalable routes and reduced purification costs.
Patent CN109851594A reveals a furan-based route for 3-aminomethyltetrahydrofuran. This method offers significant cost reduction and scalable supply chain reliability for agrochemical intermediates.
Novel 3-step process for 3-aminomethyl tetrahydrofuran via hydroformylation. Reduces cost and waste for dinotefuran production. Reliable supplier.
Patent CN109851594B details a cost-effective 5-step synthesis of 3-aminomethyl tetrahydrofuran from furan, offering significant supply chain advantages for dinotefuran production.
Patent CN104829672A reveals efficient tetrahydrofuran synthesis. Reduces costs and improves purity for reliable pharmaceutical intermediate supply chains globally.
Novel synthesis route for 3-methylamine tetrahydrofuran ensures high purity and cost efficiency for agrochemical intermediate supply chains globally.
Discover a novel L-glutamic acid route for multi-chiral tetrahydrofuran rings. High stereoselectivity and mild conditions for cost-effective API manufacturing.
Patent CN114591273A reveals a solid-state synthesis route for high-purity Alfuzosin intermediates, offering superior stability and cost reduction in pharmaceutical manufacturing.
Patent CN102276559A details a cost-effective gamma-butyrolactone route for 3-hydroxymethyltetrahydrofuran, offering high purity and scalable production for dinotefuran manufacturing.
Novel maleic diester route for 3-aminomethyltetrahydrofuran. High yield, low cost, scalable process for dinotefuran intermediates.
Novel ester-based route for (3S,4S)-2,5-dioxytetrahydrofuran-3,4-bis-benzyl carbamate eliminates Pd/C, reducing costs and improving scalability for chiral catalyst manufacturing.
Patent CN110396072B details a cost-effective dual-catalyst route for (S)-3-hydroxytetrahydrofuran, offering high optical purity and scalable manufacturing for global pharmaceutical supply chains.